One of the most significant hurdles in commercializing nano-enabled biomedical products is navigating the uncertain regulatory path.
On Tuesday May 17 COIN will be hosting a dialogue with the FDA to better understand critical nanobio regulatory issues.
The Roundtable will begin with a presentation by Katherine Tyner, a Chemist in the Center for Drug Evaluation & Research at the FDA. Dr. Tyner will speak generally on nanomedicine issues from a research perspective and how current FDA guidances apply to nanomedicine products.
Dr. Tyner will then join a panel discussion composed of experts in the nanomedicine regulatory space, including Nancy Teague, Executive Director, Regulatory Affairs, Global Regulatory Operations and Medical Device and Diagnostic Consulting with PPD as well as Lawrence Tamarkin PhD - CEO of CytImmune Sciences a global leader in the field of nanomedicine with the successful completion of its first-in-man targeted nanotherapeutic clinical trial. This panel will be moderated by Don Alexander of Carlyle & Conlan. Read more
5:00 - 5:30 Registration and networking
5:30 - 6:00 Dr Katherine Tyner, FDA
6:00 - 7:00 Panel Discussion
Don Alexander - VP of Life Sciences Development and Commercialization, Carlyle and Conlan Panelists: Katherine Tyner - FDA Center for Drug Evaluation & Research Nancy Teague – PPD Global Regulatory Consulting Lawrence Tamarkin, PhD - CytImmune Sciences
Don Alexander - VP of Life Sciences Development and Commercialization, Carlyle and Conlan
Katherine Tyner - FDA Center for Drug Evaluation & Research
Nancy Teague – PPD Global Regulatory Consulting
Lawrence Tamarkin, PhD - CytImmune Sciences
7:00 - 8:00 Networking and prize drawing winner announced
Have you entered our prize drawing? Be sure to "Follow" the sponsors and key supporters featured on our newsletter for your chance to win an ipod nano
Hors d'oeuvres and drinks will begin at 5pm
12 Davis Drive
Research Triangle Park
Who Should Attend?
Business executives & managers
Others interested in nanobiotechnology
Interact with nanobio business professionals, scientists, potential partners, and customers
Learn more about key challenges facing the community and hear success stories from business/thought leaders
Source new business/research capabilities and identify new innovations and technology
Space is limited so avoid disappointment and RSVP today!
Additional sponsorship opportunities are available.
The Venable Center, 303 South Roxboro Street, Suite 30, Durham NC 27701
When & Where
Book your place using the Register button above.
Call: Clare Valcore on 919 680 2070
COIN is a nonprofit organization that promotes innovation and commercialization in the fields of nanobiotechnology and nanomedicine to enable future economic growth and improve human life.